As a result, this leads to inhibition of CTLA4 and PD-1 pathways, which were considered the most important immunoregulatory pathways that configure immune responses in a variety of immunological disorders including cancers and autoimmune diseases. Here, CTLA4 is linked to autoimmune disease.